DK0791355T3 - Fremgangsmåde til reduktion af vævsbeskadigelse forbundet med iskæmi - Google Patents
Fremgangsmåde til reduktion af vævsbeskadigelse forbundet med iskæmiInfo
- Publication number
- DK0791355T3 DK0791355T3 DK97200415T DK97200415T DK0791355T3 DK 0791355 T3 DK0791355 T3 DK 0791355T3 DK 97200415 T DK97200415 T DK 97200415T DK 97200415 T DK97200415 T DK 97200415T DK 0791355 T3 DK0791355 T3 DK 0791355T3
- Authority
- DK
- Denmark
- Prior art keywords
- ischemia
- tissue damage
- reducing tissue
- damage associated
- reducing
- Prior art date
Links
- 208000028867 ischemia Diseases 0.000 title abstract 2
- 230000000451 tissue damage Effects 0.000 title abstract 2
- 231100000827 tissue damage Toxicity 0.000 title abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 229940123659 Sorbitol dehydrogenase inhibitor Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Reproductive Health (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1270896P | 1996-02-29 | 1996-02-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0791355T3 true DK0791355T3 (da) | 2002-06-17 |
Family
ID=21756305
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK97200415T DK0791355T3 (da) | 1996-02-29 | 1997-02-13 | Fremgangsmåde til reduktion af vævsbeskadigelse forbundet med iskæmi |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5932581A (da) |
| EP (1) | EP0791355B1 (da) |
| JP (1) | JPH09316004A (da) |
| KR (1) | KR100219972B1 (da) |
| CN (1) | CN1165000A (da) |
| AT (1) | ATE216226T1 (da) |
| AU (1) | AU714038B2 (da) |
| CA (1) | CA2198536C (da) |
| DE (1) | DE69711965T2 (da) |
| DK (1) | DK0791355T3 (da) |
| ES (1) | ES2174176T3 (da) |
| IL (1) | IL120271A (da) |
| MY (1) | MY118982A (da) |
| PT (1) | PT791355E (da) |
| ZA (1) | ZA971715B (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AP2005003199A0 (en) * | 1999-04-01 | 2005-03-31 | Pfizer Prod Inc | Aminopyrimidines as sorbitol dehydrogenase inhibitors |
| US6825198B2 (en) * | 2001-06-21 | 2004-11-30 | Pfizer Inc | 5-HT receptor ligands and uses thereof |
| CN104346404B (zh) * | 2013-08-08 | 2018-05-18 | 华为技术有限公司 | 一种访问数据的方法、设备及系统 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3905364A1 (de) | 1989-02-22 | 1990-08-23 | Hoechst Ag | Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als tool |
| DE4025387A1 (de) | 1990-08-10 | 1992-02-13 | Hoechst Ag | Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als reagenzien |
| US5728704A (en) | 1992-09-28 | 1998-03-17 | Pfizer Inc. | Substituted pyridmidines for control of diabetic complications |
-
1997
- 1997-02-13 DE DE69711965T patent/DE69711965T2/de not_active Expired - Fee Related
- 1997-02-13 AT AT97200415T patent/ATE216226T1/de not_active IP Right Cessation
- 1997-02-13 PT PT97200415T patent/PT791355E/pt unknown
- 1997-02-13 DK DK97200415T patent/DK0791355T3/da active
- 1997-02-13 ES ES97200415T patent/ES2174176T3/es not_active Expired - Lifetime
- 1997-02-13 EP EP97200415A patent/EP0791355B1/en not_active Expired - Lifetime
- 1997-02-20 IL IL12027197A patent/IL120271A/en not_active IP Right Cessation
- 1997-02-20 US US08/803,302 patent/US5932581A/en not_active Expired - Fee Related
- 1997-02-25 JP JP9040466A patent/JPH09316004A/ja active Pending
- 1997-02-26 CA CA002198536A patent/CA2198536C/en not_active Expired - Fee Related
- 1997-02-27 ZA ZA971715A patent/ZA971715B/xx unknown
- 1997-02-27 MY MYPI97000795A patent/MY118982A/en unknown
- 1997-02-27 KR KR1019970006295A patent/KR100219972B1/ko not_active Expired - Fee Related
- 1997-02-28 AU AU15009/97A patent/AU714038B2/en not_active Ceased
- 1997-02-28 CN CN97103411A patent/CN1165000A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ES2174176T3 (es) | 2002-11-01 |
| ZA971715B (en) | 1998-08-27 |
| CA2198536C (en) | 2000-06-20 |
| CN1165000A (zh) | 1997-11-19 |
| JPH09316004A (ja) | 1997-12-09 |
| AU714038B2 (en) | 1999-12-16 |
| DE69711965T2 (de) | 2003-01-23 |
| CA2198536A1 (en) | 1997-08-29 |
| AU1500997A (en) | 1997-09-04 |
| ATE216226T1 (de) | 2002-05-15 |
| KR100219972B1 (ko) | 1999-09-01 |
| DE69711965D1 (de) | 2002-05-23 |
| MX9701527A (es) | 1998-06-30 |
| PT791355E (pt) | 2002-08-30 |
| EP0791355A1 (en) | 1997-08-27 |
| IL120271A (en) | 2001-06-14 |
| EP0791355B1 (en) | 2002-04-17 |
| IL120271A0 (en) | 1997-06-10 |
| KR970061257A (ko) | 1997-09-12 |
| US5932581A (en) | 1999-08-03 |
| MY118982A (en) | 2005-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69526237D1 (de) | Chirurgische gesichtsmaske | |
| BR9707758A (pt) | Corpo otico | |
| BR9707766A (pt) | Corpo ótico | |
| DE69705401D1 (de) | Gesichtsmaske | |
| FI961886L (fi) | Ihmisen Kunitz-tyyppiset proteaasi-inhibiittorit | |
| IL120264A0 (en) | Method of reducing tissue damage associated with non-cardiac ischemia | |
| NO20010556D0 (no) | Fremgangsmåte for oftalmisk administrering | |
| DE69429265D1 (de) | Medizinabgabe | |
| NO952977D0 (no) | Aminoduhydro-kosopurinyl-metoksypropandiolderivater | |
| DK0764157T3 (da) | Benzopyraner og deres anvendelse som terapeutiske midler | |
| DK0791355T3 (da) | Fremgangsmåde til reduktion af vævsbeskadigelse forbundet med iskæmi | |
| DE59400353D1 (de) | Am Kopf tragbares Hörgerät | |
| DE69100171D1 (de) | Synergistische kombination zur ophthalmischen verwendung. | |
| EE9400040A (et) | Oftalmiliseks otstarbeks mõeldud kompositsioon | |
| DK0458537T3 (da) | Anvendelse af en terapeutisk forbindelse til behandling af bronkitis | |
| KR950010913U (ko) | 지속형 팬티 기저귀 | |
| DK0721781T3 (da) | Reduktion af fedtvæv under anvendelse af kollagenase | |
| ES1028186Y (es) | Pañuelo monouso. | |
| KR950029532U (ko) | 환자용 기저귀 | |
| ITPD930207A0 (it) | Scacchiera perfezionata | |
| ES1023597Y (es) | Vendaje terapeutico perfeccionado. | |
| DE69820049D1 (de) | Medizinische Gesichtsmaske | |
| ES1028931Y (es) | Estructura perfeccionada para nichos funerarios. | |
| IT229501Y1 (it) | Strumento per controllo punteggio ottenuto su schedine totocalcio ad uso diretto del giocatore | |
| NO934049D0 (no) | Fremgangsmaate for terapi |